Clinical Trial Update: Risk of SDRs Under 3HP and 1HP Regimen for LTBI [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating risk of serious adverse drug reactions (SDRs) with 3HP and 1HP regimens for latent tuberculosis infection has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Latent Tuberculosis Infection | Phase 3 | Status: COMPLETED